CCI has a diverse portfolio of innovative technologies and Spin-off companies focused on bringing Clinic technology to market.
The portfolio of Spin-offs include device, diagnostic, biopharma and healthcare IT companies from concept stage through IPO. To date, one company has had a public offering and three companies have been acquired.
In addition to our Spin-offs, CCI’s rich portfolio of Cleveland Clinic technologies span the entire continuum of care and all medical arenas. Health Information Technology is our fastest growing segment, and continues to make great strides in making care more efficient. If interested in investing or licensing, please contact our team who can walk you through all options available.
Tolera Therapeutics, Inc. develops antibodies and therapies that will prepare patients for an upcoming transplant, thus reducing the chances for rejection.
Talis Clinical commercializes an Anesthesia information management system that has been used in Cleveland Clinic operating rooms since 2010
Prior to joining CCI, Mr. O'Neill was Deputy Director of Battelle's Great Lakes Industrial Technology Center, where he facilitated licenses and other technology transfer partnerships with the NASA Glenn Research Center. Previously, he worked as a process engineer for a number of investment casting companies, supplying turbine blades to gas turbine engine manufacturers. Peter received a B.S. in aeronautical engineering from MIT. At CCI he is focusing on commercializing MEMS, orthopedic, and other medical device technologies.
Sam's main focus is development, finance and growth of new spin-offs. Prior to joining CCI, he was responsible for Clinic Care, an arm of the Cleveland Clinic, which provides multifunctional support for the Clinic and subsidiaries. Sam has extensive experience in business development and has been involved in the organization and start-up of a number of companies. He has served on the Board of Directors for over 20 companies, acting as initial treasurer of each company and providing active leadership in guiding them toward maximizing the patient benefit of the technology, along with bringing the maximum financial return from the technology. Currently, Sam serves on the board of directors for FlexLife (Co-Chairman); ImageIQ; Renovo Neural, Inc.; Navis Medical, Inc.; Perfusion Solutions, Inc.; OptoQuest Corp.; and the Foundation for Humanitarian Aid. Prior to the Cleveland Clinic, Sam started and led a highly successful business enterprise and held executive financial positions with several organizations. He holds several issued US and international patents. Sam received his BS in Accounting, MBA and PhD in Economics from Moscow State University.
Learn about upcoming education events.
Innovations has facilitated several Cleveland Clinic Spin-Offs over the last decade. Click here to see our current portfolio.
Cleveland Clinic © 2014